Burchardt U
Z Urol Nephrol. 1977 Jan;70(1):7-11.
It is described a test for the presence of diffuse nephropathies which is based on the fact that after application 20 ml of the renal diatrizoate X-ray contrast medium Visotrast or of 500 ml of a 10% mannitol solution in patients with preexisting renal diseases appear reversible, diagnostically relevant increases of the alanine aminopeptidase excretion with the urine. In persons with healthy kidneys the excretion of enzymes changes insignificantly. The increased excretion of alanine aminopeptidase is also observed in patients with latent pyelonephritis and is traced back to the increased formation of an osmotic nephropathy in patients with preexisting nephropathies.
描述了一种针对弥漫性肾病的检测方法,该方法基于以下事实:在已有肾脏疾病的患者中,应用20毫升肾泛影葡胺X射线造影剂维索特拉(Visotrast)或500毫升10%甘露醇溶液后,尿中丙氨酸氨基肽酶排泄量会出现可逆的、具有诊断意义的增加。在肾脏健康的人中,酶的排泄变化不明显。在潜伏性肾盂肾炎患者中也观察到丙氨酸氨基肽酶排泄增加,这可追溯到已有肾病患者中渗透性肾病形成增加。